CIK: 0001263508 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value ($000): $15,621,759 (99.4% shares, 0.6% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 51,049,760 | $3,738,884 | 23.9% | $37.84 | — | COM | 812578102 |
| INCY | Incyte Corporation | 34,271,827 | $2,947,720 | 18.9% | $73.07 | +11.4% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 11,959,824 | $1,578,697 | 10.1% | $117.58 | — | SPONSORED ADR | 07725L102 |
| — | Alexion Pharmaceuticals, Inc. | 8,558,068 | $1,156,880 | 7.4% | $166.88 | — | COM | 015351109 |
| ACAD | ACADIA Pharmaceuticals Inc. | 39,713,842 | $1,066,317 | 6.8% | $17.80 | +31.2% | COM | 004225108 |
| — | Amarin Corporation plc | 43,210,459 | $897,049 | 5.7% | $8.93 | — | SPONSORED ADR | 023111206 |
| — | Genomic Health, Inc. | 10,198,943 | $714,436 | 4.6% | $31.71 | — | COM | 37244C101 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $674,157 | 4.3% | $81.02 | +14.4% | COM | 09061G101 |
| ASND | Ascendis Pharma A/S | 3,390,270 | $399,035 | 2.6% | $44.21 | — | SPONSORED ADR | 04351P101 |
| — | Mirati Therapeutics, Inc. | 2,513,462 | $184,237 | 1.2% | $18.61 | — | COM | 60468T105 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,169,278 | $146,464 | 0.9% | $110.87 | +12.1% | COM | 558868105 |
| ARGX | argenx SE | 1,019,557 | $127,281 | 0.8% | $59.75 | — | SPONSORED ADR | 04016X101 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 15,118,081 | $123,061 | 0.8% | $6.96 | +23.0% | COM | 09058V103 |
| HRTX | Heron Therapeutics, Inc. | 5,018,104 | $122,642 | 0.8% | $17.34 | +51.0% | COM | 427746102 |
| — | Clementia Pharmaceuticals Inc. | 3,724,445 | $97,208 | 0.6% | $12.34 | — | COM | 185575107 |
| NBIX | Neurocrine Biosciences, Inc. | 1,098,670 | $96,793 | 0.6% | $57.33 | +45.8% | COM | 64125C109 |
| — | Array BioPharma Inc. | 3,842,289 | $93,675 | 0.6% | $10.76 | — | COM | 04269X105 |
| — | Invitae Corporation | 3,902,421 | $91,395 | 0.6% | $14.39 | — | COM | 46185L103 |
| — | Spark Therapeutics, Inc. | 751,927 | $85,629 | 0.5% | $76.99 | — | COM | 84652J103 |
| — | CymaBay Therapeutics, Inc. | 5,707,411 | $75,794 | 0.5% | $9.54 | — | COM | 23257D103 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,708,200 | $74,232 | 0.5% | $26.63 | +7.9% | COM | 76243J105 |
| — | GW Pharmaceuticals plc | 428,345 | $72,206 | 0.5% | $132.99 | — | ADS | 36197T103 |
| — | Neurocrine Biosciences, Inc. | 53,270,000 | $71,994 | 0.5% | $1.24 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| — | Tricida, Inc. | 1,803,238 | $69,641 | 0.4% | $30.88 | — | COM | 89610F101 |
| CERS | Cerus Corporation | 10,749,937 | $66,972 | 0.4% | $4.67 | +29.9% | COM | 157085101 |
| — | Audentes Therapeutics, Inc. | 1,715,183 | $66,926 | 0.4% | $31.63 | — | COM | 05070R104 |
| — | Principia Biopharma Inc. | 1,787,807 | $60,785 | 0.4% | $29.22 | — | COM | 74257L108 |
| INSM | Insmed Incorporated | 2,077,601 | $60,396 | 0.4% | $20.87 | +24.2% | COM PAR $.01 | 457669307 |
| KOD | Kodiak Sciences Inc. | 9,145,115 | $59,718 | 0.4% | $8.85 | -16.5% | COM | 50015M109 |
| — | Kiniksa Pharmaceuticals, Ltd. | 3,000,000 | $54,180 | 0.3% | $17.35 | — | COM CL A | G5269C101 |
| — | MyoKardia, Inc. | 1,016,306 | $52,838 | 0.3% | $48.30 | — | COM | 62857M105 |
| — | DBV Technologies S.A. | 5,509,560 | $42,479 | 0.3% | $32.87 | — | SPONSORED ADR | 23306J101 |
| QURE | uniQure N.V. | 605,000 | $36,088 | 0.2% | $18.33 | +143.7% | SHS | N90064101 |
| — | Aquinox Pharmaceuticals, Inc. | 10,934,154 | $29,468 | 0.2% | $13.36 | — | COM | 03842B101 |
| — | Zymeworks Inc. | 1,708,472 | $27,643 | 0.2% | $14.76 | — | COM | 98985W102 |
| KRYS | Krystal Biotech, Inc. | 784,674 | $25,816 | 0.2% | $19.35 | +21.8% | COM | 501147102 |
| — | Ra Pharmaceuticals, Inc. | 823,113 | $18,438 | 0.1% | $17.55 | — | COM | 74933V108 |
| — | Merus N.V. | 1,160,014 | $17,133 | 0.1% | $8.27 | — | COM | N5749R100 |
| AXSM | Axsome Therapeutics, Inc. | 1,200,000 | $17,076 | 0.1% | $9.29 | 0.0% | COM | 05464T104 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $15,385 | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $15,062 | 0.1% | $16.20 | — | COM | 00900T107 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 2,900,000 | $14,790 | 0.1% | $2.70 | +8.8% | COM | 14888U101 |
| — | Aeglea BioTherapeutics, Inc. | 1,713,604 | $13,795 | 0.1% | $5.64 | — | COM | 00773J103 |
| XNCR | Xencor, Inc. | 428,120 | $13,297 | 0.1% | $11.07 | +200.7% | COM | 98401F105 |
| — | Idera Pharmaceuticals, Inc. | 4,839,895 | $12,342 | 0.1% | $1.32 | — | COM PAR | 45168K405 |
| — | Dermira, Inc. | 906,943 | $12,289 | 0.1% | $13.55 | — | COM | 24983L104 |
| — | Marker Therapeutics, Inc. | 1,500,000 | $9,900 | 0.1% | $5.55 | — | COM | 57055L107 |
| SGMO | Sangamo Therapeutics, Inc. | 999,823 | $9,538 | 0.1% | $11.28 | -9.5% | COM | 800677106 |
| — | Abeona Therapeutics Inc. | 1,288,235 | $9,481 | 0.1% | $7.28 | — | COM | 00289Y107 |
| — | Bellicum Pharmaceuticals, Inc. | 2,677,818 | $9,024 | 0.1% | $22.31 | — | COM | 079481107 |
| ANAB | AnaptysBio, Inc. | 113,086 | $8,261 | 0.1% | $56.96 | +21.2% | COM | 032724106 |
| — | Albireo Pharma, Inc. | 250,000 | $8,053 | 0.1% | $22.99 | — | COM | 01345P106 |
| IFRX | InflaRx N.V. | 178,987 | $6,764 | 0.0% | $21.73 | +71.4% | COM | N44821101 |
| — | Spring Bank Pharmaceuticals, Inc. | 613,144 | $6,432 | 0.0% | $10.97 | — | COM | 849431101 |
| — | bluebird bio, Inc. | 40,000 | $6,293 | 0.0% | $41.25 | — | COM | 09609G100 |
| APLS | Apellis Pharmaceuticals, Inc. | 313,725 | $6,118 | 0.0% | $20.26 | -22.4% | COM | 03753U106 |
| — | Menlo Therapeutics Inc. | 700,000 | $5,495 | 0.0% | $37.58 | — | COM | 586858102 |
| MGNX | MacroGenics, Inc. | 302,600 | $5,441 | 0.0% | $17.29 | 0.0% | COM | 556099109 |
| — | Syros Pharmaceuticals, Inc. | 574,835 | $5,254 | 0.0% | $16.82 | — | COM | 87184Q107 |
| PTGX | Protagonist Therapeutics, Inc. | 403,893 | $5,077 | 0.0% | $8.83 | 0.0% | COM | 74366E102 |
| AUTL | Autolus Therapeutics plc | 156,773 | $4,934 | 0.0% | $26.79 | — | SPON ADS | 05280R100 |
| HALO | Halozyme Therapeutics, Inc. | 299,969 | $4,830 | 0.0% | $7.32 | +121.3% | COM | 40637H109 |
| VKTX | Viking Therapeutics, Inc. | 425,000 | $4,225 | 0.0% | $11.90 | -29.7% | COM | 92686J106 |
| — | Forty Seven, Inc. | 250,000 | $4,040 | 0.0% | $16.00 | — | COM | 34983P104 |
| — | Acceleron Pharma Inc. | 83,900 | $3,907 | 0.0% | $37.72 | — | COM | 00434H108 |
| — | Acorda Therapeutics, Inc. | 292,134 | $3,882 | 0.0% | $13.29 | — | COM | 00484M106 |
| — | Sierra Oncology, Inc. | 2,000,000 | $3,420 | 0.0% | $1.32 | — | COM | 82640U107 |
| — | La Jolla Pharmaceutical Company | 505,240 | $3,249 | 0.0% | $13.43 | — | COM PAR $.0001 2 | 503459604 |
| — | Achillion Pharmaceuticals, Inc. | 1,095,359 | $3,242 | 0.0% | $6.34 | — | COM | 00448Q201 |
| — | Aravive, Inc. | 430,885 | $3,033 | 0.0% | $3.74 | — | COM | 03890D108 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 131,250 | $2,987 | 0.0% | $29.69 | -17.2% | COM | 22663K107 |
| GLPG | Galapagos NV | 25,072 | $2,953 | 0.0% | $51.50 | — | SPONSORED ADR | 36315X101 |
| — | Assembly Biosciences, Inc. | 148,587 | $2,926 | 0.0% | $20.45 | — | COM | 045396108 |
| — | ChemoCentryx, Inc. | 207,029 | $2,876 | 0.0% | $13.66 | — | COM | 16383L106 |
| — | Y-mAbs Therapeutics, Inc. | 102,800 | $2,694 | 0.0% | $26.56 | — | COM | 984241109 |
| ALKS | Alkermes plc | 67,000 | $2,445 | 0.0% | $70.02 | -52.8% | SHS | G01767105 |
| — | Orchard Therapeutics plc | 125,000 | $2,235 | 0.0% | $15.73 | — | ADS | 68570P101 |
| NTLA | Intellia Therapeutics, Inc. | 128,538 | $2,195 | 0.0% | $26.35 | -43.4% | COM | 45826J105 |
| — | G1 Therapeutics, Inc. | 127,236 | $2,112 | 0.0% | $37.05 | — | COM | 3621LQ109 |
| CTMX | CytomX Therapeutics, Inc. | 194,377 | $2,090 | 0.0% | $14.78 | 0.0% | COM | 23284F105 |
| — | Harpoon Therapeutics, Inc. | 214,285 | $2,029 | 0.0% | $9.47 | — | COM | 41358P106 |
| — | Foamix Pharmaceuticals Ltd. | 498,189 | $1,868 | 0.0% | $7.55 | — | SHS | M46135105 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $1,807 | 0.0% | $6.73 | — | COM | 210373106 |
| — | Galmed Pharmaceuticals Ltd. | 215,594 | $1,761 | 0.0% | $11.90 | — | SHS | M47238106 |
| RCUS | Arcus Biosciences, Inc. | 121,534 | $1,518 | 0.0% | $15.69 | -30.8% | COM | 03969F109 |
| — | Molecular Templates, Inc. | 254,230 | $1,477 | 0.0% | $5.84 | — | COM | 608550109 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $1,227 | 0.0% | $14.46 | — | COM | 00548A106 |
| — | ContraFect Corporation | 2,914,536 | $1,159 | 0.0% | $1.88 | — | COM | 212326102 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $1,091 | 0.0% | $1.54 | -4.8% | COM | 45665G303 |
| — | Affimed N.V. | 200,000 | $840 | 0.0% | $6.30 | — | COM | N01045108 |
| FLGT | Fulgent Genetics, Inc. | 125,000 | $744 | 0.0% | $9.20 | -50.3% | COM | 359664109 |
| AQST | Aquestive Therapeutics, Inc. | 99,600 | $688 | 0.0% | $16.48 | -57.5% | COM | 03843E104 |
| — | Sunesis Pharmaceuticals, Inc. | 556,665 | $676 | 0.0% | $4.37 | — | COM PAR | 867328700 |
| — | Dynavax Technologies Corporation | 75,000 | $548 | 0.0% | $24.55 | — | COM | 268158201 |
| — | Trillium Therapeutics Inc. | 505,262 | $333 | 0.0% | $12.19 | — | COM | 89620X506 |
| — | Ritter Pharmaceuticals, Inc. | 279,999 | $244 | 0.0% | $2.72 | — | COM | 767836307 |